{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:18Z","timestamp":1786980558053,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-023-03810-5","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:02:01Z","timestamp":1686888121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-9551","authenticated-orcid":false,"given":"Qaisar Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8724-3969","authenticated-orcid":false,"given":"Parsa","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-2816","authenticated-orcid":false,"given":"Christopher","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-481X","authenticated-orcid":false,"given":"Michelle R.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-4837","authenticated-orcid":false,"given":"Akshai","family":"Chundru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-0897","authenticated-orcid":false,"given":"Faiza","family":"Amatul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya","family":"Parimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2270-9497","authenticated-orcid":false,"given":"Natalia","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-1551","authenticated-orcid":false,"given":"Matthew","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-7246","authenticated-orcid":false,"given":"Sumaira","family":"Iram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-0899","authenticated-orcid":false,"given":"Arooba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"3810_CR1","unstructured":"Basit H, Godse KV, Al Aboud AM. Melasma. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459271\/"},{"issue":"3","key":"3810_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb) 7(3):305\u2013318. https:\/\/doi.org\/10.1007\/s13555-017-0194-1","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"3810_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.det.2018.12.008","volume":"37","author":"R Zubair","year":"2019","unstructured":"Zubair R, Lyons AB, Vellaichamy G, Peacock A, Hamzavi I (2019) What\u2019s new in pigmentary disorders. Dermatol Clin\u00a037(2):175\u2013181. https:\/\/doi.org\/10.1016\/j.det.2018.12.008","journal-title":"Dermatol Clin."},{"issue":"8","key":"3810_CR4","first-page":"E73","volume":"12","author":"JV Wang","year":"2019","unstructured":"Wang JV, Jhawar N, Saedi N (2019) Tranexamic acid for melasma: evaluating the various formulations. J Clin Aesthet Dermatol 12(8):E73\u2013E74","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"3810_CR5","first-page":"40","volume":"10","author":"B Tian","year":"2017","unstructured":"Tian B (2017) The Asian problem of frequent laser toning for melasma. J Clin Aesthet Dermatol\u00a010(7):40\u201342","journal-title":"J Clin Aesthet Dermatol."},{"key":"3810_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3810_CR7","doi-asserted-by":"crossref","unstructured":"Khan QA, Michelle A, Farkouh C, Chundru A, Farkouh M, Parimi  K, Amatul-Hadi\u00a0F (2023) Efficacy and safety of laser and topical tranexamic acid combination therapy in melasma _ A systematic review and meta-analysis of randomized controlled trials. Prospero. Available from\u00a0https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023385052","DOI":"10.1007\/s10103-023-03810-5"},{"key":"3810_CR8","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia.\u00a0www.covidence.org."},{"key":"3810_CR9","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC (2022) Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane"},{"key":"3810_CR10","unstructured":"Review Manager (RevMan) (2020) [Computer program]. Version 5.4, The Cochrane Collaboration"},{"key":"3810_CR11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s10103-022-03547-7","volume":"37","author":"A Botsali","year":"2022","unstructured":"Botsali A, Esme P, Erbil H et al (2022) Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma. Lasers Med Sci 37:2823\u20132830. https:\/\/doi.org\/10.1007\/s10103-022-03547-7","journal-title":"Lasers Med Sci"},{"key":"3810_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s10103-020-03045-8","volume":"35","author":"R Wanitphakdeedecha","year":"2020","unstructured":"Wanitphakdeedecha R, Sy-Alvarado F, Patthamalai P et al (2020) The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study. Lasers Med Sci 35:2015\u20132021. https:\/\/doi.org\/10.1007\/s10103-020-03045-8","journal-title":"Lasers Med Sci"},{"key":"3810_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/lsm.23032","volume":"51","author":"SO Tawfic","year":"2019","unstructured":"Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M (2019) Assessment of combined fractional CO2 and tranexamic acid in melasma treatment. Lasers Surg Med 51:27\u201333. https:\/\/doi.org\/10.1002\/lsm.23032","journal-title":"Lasers Surg Med."},{"key":"3810_CR14","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1111\/jocd.14532","volume":"21","author":"B Debasmita","year":"2022","unstructured":"Debasmita B, Raj C, Ishan A, Ipsita D (2022) A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma. J Cosmet Dermatol\u00a021:2801\u20132807. https:\/\/doi.org\/10.1111\/jocd.14532","journal-title":"J Cosmet Dermatol."},{"key":"3810_CR15","volume-title":"Effectiveness of 4% tranexamic acid cream and low-fluence QS Nd:YAG 10 hu 64-nm laser on melasma: a double-blind, randomized and controlled study","author":"D Ariembi","year":"2020","unstructured":"Ariembi, Dhesi, Retno Indar Widayati and Diah Adriani Malik. \u201cEffectiveness of 4% tranexamic acid cream and low-fluence QS Nd:YAG 10 hu 64-nm laser on melasma: a double-blind, randomized and controlled study.\u201d (2020)"},{"key":"3810_CR16","doi-asserted-by":"publisher","unstructured":"Li T, Yan X, Ting L, Rui Y (2020) Observation on the effect of Nd: YAG 1064nm laser combined with topical tranexamic acid on chloasma. In: 2020 International Conference on Public Health and Data Science (ICPHDS), Guangzhou, China, pp 302\u2013306. https:\/\/doi.org\/10.1109\/ICPHDS51617.2020.00065","DOI":"10.1109\/ICPHDS51617.2020.00065"},{"issue":"6","key":"3810_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/14764172.2018.1427869","volume":"20","author":"V Laothaworn","year":"2018","unstructured":"Laothaworn V, Juntongjin P (2018) Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. J Cosmet Laser Ther 20(6):320\u2013325. https:\/\/doi.org\/10.1080\/14764172.2018.1427869","journal-title":"J Cosmet Laser Ther"},{"key":"3810_CR18","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s10103-022-03566-4","volume":"37","author":"Y Li","year":"2022","unstructured":"Li Y, Yao C, Zhang H et al (2022) Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuvenation: a multicenter, randomized, double-blinded, split-face study in Chinese patients. Lasers Med Sci 37:2879\u20132887. https:\/\/doi.org\/10.1007\/s10103-022-03566-4","journal-title":"Lasers Med Sci"},{"key":"3810_CR19","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/jocd.13992","volume":"20","author":"Y Qu","year":"2021","unstructured":"Qu Y, Wang F, Liu J, Xia X (2021) Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol 20:1110\u20131116. https:\/\/doi.org\/10.1111\/jocd.13992","journal-title":"J Cosmet Dermatol."},{"key":"3810_CR20","doi-asserted-by":"publisher","unstructured":"BMJ (OPEN ACCESS) Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"4","key":"3810_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","volume":"65","author":"VM Sheth","year":"2011","unstructured":"Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part I. J Am Acad Dermatol\u00a065(4):689\u2013697. https:\/\/doi.org\/10.1016\/j.jaad.2010.12.046","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"3810_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/exd.13844","volume":"28","author":"SH Kwon","year":"2019","unstructured":"Kwon SH, Na JI, Choi JY, Park KC (2019) Melasma: updates and perspectives. Exp Dermatol\u00a028(6):704\u2013708. https:\/\/doi.org\/10.1111\/exd.13844","journal-title":"Exp Dermatol."},{"issue":"8","key":"3810_CR23","doi-asserted-by":"publisher","first-page":"e28547","DOI":"10.7759\/cureus.28547","volume":"14","author":"S Mushtaq","year":"2022","unstructured":"Mushtaq S, Sibgha Naz S, Rizwan M, Jehangir Khan N, Ullah O, Muhammad A (2022) Comparison of the efficacy of intralesional tranexamic acid versus topical 4% hydroquinone in treating melasma. Cureus\u00a014(8):e28547. https:\/\/doi.org\/10.7759\/cureus.28547","journal-title":"Cureus."},{"issue":"1","key":"3810_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13555-014-0046-1","volume":"4","author":"DS KrupaShankar","year":"2014","unstructured":"KrupaShankar DS, Somani VK, Kohli M et al (2014) A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther (Heidelb)\u00a04(1):71\u201381. https:\/\/doi.org\/10.1007\/s13555-014-0046-1","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"1","key":"3810_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jocd.12026","volume":"12","author":"TW Tse","year":"2013","unstructured":"Tse TW, Hui E (2013) Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol\u00a012(1):57\u201366. https:\/\/doi.org\/10.1111\/jocd.12026","journal-title":"J Cosmet Dermatol."},{"issue":"1","key":"3810_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijwd.2017.01.004","volume":"3","author":"MK Trivedi","year":"2017","unstructured":"Trivedi MK, Yang FC, Cho BK (2017) A review of laser and light therapy in melasma. Int J Womens Dermatol\u00a03(1):11\u201320. https:\/\/doi.org\/10.1016\/j.ijwd.2017.01.004","journal-title":"Int J Womens Dermatol."},{"issue":"2","key":"3810_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TG, Goh CL (2016) Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 75(2):385\u2013392. https:\/\/doi.org\/10.1016\/j.jaad.2016.03.001","journal-title":"J Am Acad Dermatol."},{"issue":"6-8","key":"3810_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/14764172.2022.2148186","volume":"24","author":"J Feng","year":"2022","unstructured":"Feng J, Shen S, Song X, Xiang W (2022) Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta-analysis. J Cosmet Laser Ther\u00a024(6-8):73\u201379. https:\/\/doi.org\/10.1080\/14764172.2022.2148186","journal-title":"J Cosmet Laser Ther."},{"issue":"6","key":"3810_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4103\/ijd.IJD_488_17","volume":"62","author":"R Sarkar","year":"2017","unstructured":"Sarkar R, Aurangabadkar S, Salim T et al (2017) Lasers in melasma: a review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol\u00a062(6):585\u2013590. https:\/\/doi.org\/10.4103\/ijd.IJD_488_17","journal-title":"Indian J Dermatol."}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-023-03810-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T01:05:17Z","timestamp":1703207117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-023-03810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3810"],"URL":"https:\/\/doi.org\/10.1007\/s10103-023-03810-5","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"29 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript did not require patient consent as no patients were directly utilized. Additionally, the authors consent for the work to be published and utilized in other works that are of benefit to the medical and scientific communities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"139"}}